BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31391272)

  • 1. Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.
    Zhao C; Princiotto AM; Nguyen HT; Zou S; Zhao ML; Zhang S; Herschhorn A; Farrell M; Pahil K; Melillo B; Sambasivarao SV; Abrams C; Smith AB; Madani N; Sodroski J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31391272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
    Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
    J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.
    Murray EJ; Leaman DP; Pawa N; Perkins H; Pickford C; Perros M; Zwick MB; Butler SL
    J Virol; 2010 Jul; 84(14):7288-99. PubMed ID: 20427524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
    Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry.
    Herschhorn A; Gu C; Espy N; Richard J; Finzi A; Sodroski JG
    Nat Chem Biol; 2014 Oct; 10(10):845-52. PubMed ID: 25174000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.
    Zhang Z; Wang Q; Nguyen HT; Chen HC; Chiu TJ; Smith Iii AB; Sodroski JG
    J Virol; 2023 Sep; 97(9):e0059223. PubMed ID: 37696048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
    Castillo-Menendez LR; Nguyen HT; Sodroski J
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
    Espy N; Pacheco B; Sodroski J
    Virology; 2017 Aug; 508():90-107. PubMed ID: 28521215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.
    Haim H; Si Z; Madani N; Wang L; Courter JR; Princiotto A; Kassa A; DeGrace M; McGee-Estrada K; Mefford M; Gabuzda D; Smith AB; Sodroski J
    PLoS Pathog; 2009 Apr; 5(4):e1000360. PubMed ID: 19343205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins.
    Zou S; Zhang S; Gaffney A; Ding H; Lu M; Grover JR; Farrell M; Nguyen HT; Zhao C; Anang S; Zhao M; Mohammadi M; Blanchard SC; Abrams C; Madani N; Mothes W; Kappes JC; Smith AB; Sodroski J
    J Virol; 2020 May; 94(10):. PubMed ID: 32161177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement.
    Alsahafi N; Anand SP; Castillo-Menendez L; Verly MM; Medjahed H; Prévost J; Herschhorn A; Richard J; Schön A; Melillo B; Freire E; Smith AB; Sodroski J; Finzi A
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.
    Lin G; Bertolotti-Ciarlet A; Haggarty B; Romano J; Nolan KM; Leslie GJ; Jordan AP; Huang CC; Kwong PD; Doms RW; Hoxie JA
    J Virol; 2007 Sep; 81(18):9956-66. PubMed ID: 17609282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.
    Kesavardhana S; Varadarajan R
    J Virol; 2014 Sep; 88(17):9590-604. PubMed ID: 24920800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
    Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands.
    Lu M; Ma X; Reichard N; Terry DS; Arthos J; Smith AB; Sodroski JG; Blanchard SC; Mothes W
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32522853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.